Liu X - Search Results

1

Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemia.

Cai Z, Liu Y, Tang B, Wu Z, Wang Z, Lin R, Xu X, Huang Z, Ou J, Li X, Liu X, Liu Q, Zhou H. Cai Z, et al. Among authors: liu y, liu x, liu q. Leuk Lymphoma. 2022 Dec;63(13):3181-3190. doi: 10.1080/10428194.2022.2115841. Epub 2022 Sep 13. Leuk Lymphoma. 2022. PMID: 36098226

2

[Quantitative analysis of Sokal's risk index in relation to 2 therapy protocols: their respective impact on clinical remission of chronic myeloid leukemia].

Du QF, Liu XL, Liu QF, Li R, Chen Q, Zhou SY. Du QF, et al. Di Yi Jun Yi Da Xue Xue Bao. 2002 Aug;22(8):729-30. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12376263 Chinese.

3

[Analysis of prognostic factors in patients with refractory acute myeloid leukemia].

Zhang Q, Feng R, Liu QF, Liu XL, Xu B, Zheng WY, Meng FY, Zhou SY. Zhang Q, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Sep;23(9):934-6. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 13129725 Chinese.

4

[Detection of core-binding factor in acute leukemia with interphase fluorescence in situ hybridization].

Liu XL, Du QF, Song LL, Zhang S, Li R, Lin R, Liu QF, Zhou SY. Liu XL, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1038-41. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559688 Chinese.

5

[Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].

Xu B, Hu C, Miao XD, Wu YH, Yi ZS, Yang Y, Meng FY, Feng R, Liu QF, Liu XL, Zheng WY. Xu B, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1043-6. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559689 Chinese.

6

[Study of adhesion-related molecule beta1-integrin and focal adhesion kinase in chronic myeloid leukemia].

Chang X, Liu XL, Du QF, Li R, Feng R, Chen Q, Liu QF, Zhou SY. Chang X, et al. Among authors: liu xl, liu qf. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1047-9. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559690 Chinese.

7

[Modified FLAG regimen in the management of refractory acute myeloid leukemia].

Yang LJ, Meng FY, Xu B, Liu XL, Zheng WY, Zhang Y, Huang F, Xu D, Sun J, Liu QF. Yang LJ, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1054-5. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559692 Clinical Trial. Chinese.

8

[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].

Liu QF, Sun J, Zhang Y, Xu D, Liu XL, Xu B, Meng FY, Zhou SY. Liu QF, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1143-5. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14625172 Chinese.

9

[Autologous transplantation of recombinant interleukine-2 activated bone marrow for acute promyelocytic leukemia].

Liu QF, Sun J, Zhang Y, Liu XL, Xu B, Xu D, Feng R, Meng FY, Song LL, Zhou SY. Liu QF, et al. Zhonghua Yi Xue Za Zhi. 2003 Sep 25;83(18):1561-4. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14642108 Chinese.

10

[Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].

Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY. Meng FY, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Dec;23(12):1301-2, 1306. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14678896 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,721 results

Search Page

Filters